EE200200039A - Thixocortol pivalate suspension, collutate based thereon and packaging - Google Patents

Thixocortol pivalate suspension, collutate based thereon and packaging

Info

Publication number
EE200200039A
EE200200039A EEP200200039A EEP200200039A EE200200039A EE 200200039 A EE200200039 A EE 200200039A EE P200200039 A EEP200200039 A EE P200200039A EE P200200039 A EEP200200039 A EE P200200039A EE 200200039 A EE200200039 A EE 200200039A
Authority
EE
Estonia
Prior art keywords
collutate
packaging
suspension
thixocortol pivalate
pharyngeal
Prior art date
Application number
EEP200200039A
Other languages
Estonian (et)
Inventor
Doat Bernard
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE200200039A publication Critical patent/EE200200039A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cartons (AREA)
  • Detergent Compositions (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Vehicle Body Suspensions (AREA)
  • Polymerisation Methods In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention concerns a micronized aqueous suspension of toxicortol pivalate, in a solution containing a surfactant and a viscosity agent. The invention also concerns a mouth-wash based on said suspension. The invention is useful for treating inflammations in the laryngeal, bucco-pharyngeal and rhino-pharyngeal zones.
EEP200200039A 1999-07-22 2000-07-07 Thixocortol pivalate suspension, collutate based thereon and packaging EE200200039A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9909556A FR2796553B1 (en) 1999-07-22 1999-07-22 SUSPENSION OF TIXOCORTOL PIVALATE, COLLUTORY BASED ON SAME AND PACKAGING CONTAINING SAME
PCT/FR2000/001987 WO2001007053A1 (en) 1999-07-22 2000-07-07 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same

Publications (1)

Publication Number Publication Date
EE200200039A true EE200200039A (en) 2003-04-15

Family

ID=9548429

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200039A EE200200039A (en) 1999-07-22 2000-07-07 Thixocortol pivalate suspension, collutate based thereon and packaging

Country Status (25)

Country Link
EP (1) EP1200096B1 (en)
JP (1) JP2003505421A (en)
KR (1) KR100718211B1 (en)
AT (1) ATE269088T1 (en)
AU (1) AU6296700A (en)
BG (1) BG106358A (en)
BR (1) BR0012671A (en)
CA (1) CA2378390C (en)
CZ (1) CZ2002144A3 (en)
DE (1) DE60011620T2 (en)
DK (1) DK1200096T3 (en)
DZ (1) DZ3207A1 (en)
EE (1) EE200200039A (en)
ES (1) ES2219366T3 (en)
FR (1) FR2796553B1 (en)
HK (1) HK1046850B (en)
HU (1) HUP0202055A3 (en)
IS (1) IS6228A (en)
MX (1) MXPA02000834A (en)
NO (1) NO20020252L (en)
OA (1) OA11993A (en)
PL (1) PL354100A1 (en)
PT (1) PT1200096E (en)
SK (1) SK762002A3 (en)
WO (1) WO2001007053A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5317512B2 (en) * 2008-03-31 2013-10-16 小林製薬株式会社 Moisturizing composition
JP5461785B2 (en) * 2008-03-31 2014-04-02 小林製薬株式会社 Pharmaceutical composition for repeated infection prevention
JP2013123450A (en) * 2011-12-13 2013-06-24 Akihiro Sato Medical treatment method of pneumoconiosis to which metal complex ion liquid is applied, and medical treatment method of pharynx, trachea and bronchus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877781A (en) * 1987-09-30 1989-10-31 Peter G. LaHaye Medical dispenser and preparation for inflamed tissue
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
HK1046850A1 (en) 2003-01-30
IS6228A (en) 2002-01-15
CA2378390C (en) 2008-09-23
ES2219366T3 (en) 2004-12-01
DE60011620T2 (en) 2005-07-21
OA11993A (en) 2006-04-18
PL354100A1 (en) 2003-12-29
EP1200096A1 (en) 2002-05-02
BR0012671A (en) 2002-04-09
WO2001007053A1 (en) 2001-02-01
CA2378390A1 (en) 2001-02-01
DE60011620D1 (en) 2004-07-22
MXPA02000834A (en) 2003-07-14
HUP0202055A3 (en) 2009-03-30
SK762002A3 (en) 2002-08-06
KR100718211B1 (en) 2007-05-15
FR2796553A1 (en) 2001-01-26
KR20020012010A (en) 2002-02-09
NO20020252D0 (en) 2002-01-17
HK1046850B (en) 2004-12-31
DK1200096T3 (en) 2004-09-13
HUP0202055A2 (en) 2002-09-28
CZ2002144A3 (en) 2002-06-12
ATE269088T1 (en) 2004-07-15
PT1200096E (en) 2004-10-29
NO20020252L (en) 2002-01-17
FR2796553B1 (en) 2001-09-28
AU6296700A (en) 2001-02-13
EP1200096B1 (en) 2004-06-16
DZ3207A1 (en) 2001-02-01
BG106358A (en) 2002-08-30
JP2003505421A (en) 2003-02-12

Similar Documents

Publication Publication Date Title
NO20011842L (en) Stable, concentrated insulin preparations for pulmonary delivery
DE60027606D1 (en) POLYPHENOLIC PROTEIN CONTAINING BIOADHESIVE COMPOSITION
BR9811854B1 (en) process of preparing 3,3-dimethyl butyraldehyde by oxidizing 3,3-dimethylbutanol.
MX223257B (en) Coating material containing a mixture of silicic acids and urea and/or urea derivatives.
FI891570A0 (en) Process for the preparation of pharmaceutical compositions of piroxicam
FI953742A0 (en) Oxidizing agents
ATE233086T1 (en) PLASTERS CONTAINING ACTIVE INGREDIENTS
PT882726E (en) CARBAZOL-CARBOXAMID AS 5-HT1F AGONISTS
AU2323095A (en) Lactam derivatives useful for pharmaceutical purposes
GB0027405D0 (en) Composition
EE200200039A (en) Thixocortol pivalate suspension, collutate based thereon and packaging
ATE245028T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRIMEGESTONE
BR9804057A (en) Application of aminonitrile n-oxides as bleach activators.
WO2002004481A3 (en) Process to increase protein stability
EA200000963A1 (en) OPHALMOLOGICAL SOLUTION CONTAINING GLYCOGEN
MY118864A (en) Use of oxidation promoting chemicals in the oxidation of oxidizable galactose type of alcohol configuration containing polymer
TR200001122T2 (en) Biphenyl derivatives as pharmaceuticals.
ES2190267T3 (en) PLASTIC CONTAINER CONTAINING FORMULATIONS OF STABILIZED PHARMACOS.
DE50003506D1 (en) Glass powder and its use
FI20002040A7 (en) Device for transferring energy
SI0987268T1 (en) Pharmaceutical agents containing epothilone A-N-oxide and/or epothilone B-N-oxide
EP0471092A4 (en) Triazole compound and insecticide